On Friday, December 4th, 2020, our IT systems will be serviced from 12:00 p.m. – consequently, no more orders will be processed on this day … read more ›
Dear customers, the Gynemed office and warehouse will be closed from Thursday 24th December 2020 until Friday 1st January 2021. Our usual service in the … read more ›
Dear Reader, In this issue of Gynemedia we look forward to an interview with Dr. Sell regarding his professional reorientation within the Hamilton Thorne Group … read more ›
“Selection of competent oocytes by morpholoical criteria for assisted reproductive technologies” … read more ›
… GynArt for the trust they have placed in us and are once again looking forward to the successful sale of a CCM-iBIS timelapse incubator. … read more ›
Dear reader, in this latest issue, we’re especially happy to be able to introduce a new member of the Gynemed team: Mr Simon Gaisbauer, who … read more ›
We are looking forward to your visit! … read more ›
Ask for an offer … … read more ›
The monitoring audit according to DIN EN ISO 13485: 2016 of MedCert GmbH took place in our premises from June 2nd to June 3rd 2020. … read more ›
Dear Gynemed, In view of the increasing incidence of Covid-19 infection and its public health consequences, ESHRE regrets to inform you that our Annual Meeting … read more ›
Big News: We’re Growing!
Nexpring Health has completed the acquisition of Irvine Scientific’s ART and Cytogenetics
product lines, uniting media, consumables, capital equipment, and lab services under one trusted brand.
✅ Same trusted quality and support
✅ More connected solutions for your entire IVF workflow
✅ No disruption to your current ordering or service
We’re excited to bring even more value to embryologists, clinicians, and fertility clinics, because you’re at the center of everything we do.
Learn More About the Acquisition
You need to load content from reCAPTCHA to submit the form. Please note that doing so will share data with third-party providers.
More InformationYou are currently viewing a placeholder content from Turnstile. To access the actual content, click the button below. Please note that doing so will share data with third-party providers.
More Information